The invention discloses a
dual response type intelligent hydrogel
drug carrier, and relates to the technical field of biological
medicine, the preparation method comprises the following steps:
raw material pretreatment, preparation of a shell pH response prepolymerization solution, preparation of a
transition layer solution and preparation of a core
enzyme response dispersion solution, coaxial
electrospray molding, multi-stage cross-linking solidification and post-treatment purification, and construction of a core-shell structure by using specific raw materials. The preparation method has the advantages that a core-shell structure is constructed, the
cyclodextrin modified
hyaluronic acid forms a shell layer, the
adamantane modified
polylactic acid-
glycolic acid copolymer forms an inner core, pH and an
enzyme response unit are physically isolated, mechanism conflicts are avoided, and the stability of the
enzyme is improved; then through multistage crosslinking,
sequential control of a shell layer is achieved, pre-enrichment is completed through pH response adaptive
lesion edge microenvironment gradient, and after a
transition layer is degraded, an inner core is adaptive to a
lesion core gradient through enzyme response to release drugs; the defect of early
drug release or delayed
drug release caused by the fact that an existing dual-response carrier cannot adapt to the focus microenvironment gradient due to response mechanism conflicts is overcome.